Ledger.Open graph →
SEC Form D · filed December 18, 2018

Akero Therapeutics, Inc

Offering
$45.5M
Sold
$45.5M
Exemption
Rule 506(b)
Industry
Other Health Care
Location
South San Francisco, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (14)

Mark Iwicki · South San Francisco, CADirectorGraham Walmsley · South San Francisco, CADirectorKevin Bitterman · Cambridge, MADirectorAaron Kantoff · NEW YORK, NYDirectorAaron Royston · South San Francisco, CADirectorJonathan Young · South San Francisco, CAExecAndrew Cheng · VANCOUVER, British Columbia, CanadaExec · DirectorAaron Kantoff · NEW YORK, NYDirectorAaron Royston · South San Francisco, CADirectorMark Iwicki · CHELSEA, MADirectorGraham Walmsley · South San Francisco, CADirectorJonathan Young · South San Francisco, CAExecKevin Bitterman · Waltham, MADirectorAndrew Cheng · South San Francisco, CAExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗